2010
DOI: 10.2215/cjn.09081209
|View full text |Cite
|
Sign up to set email alerts
|

Treatment Options for Sexual Dysfunction in Patients with Chronic Kidney Disease

Abstract: Background and objectives: Sexual dysfunction is very common in patients with chronic kidney disease (CKD),

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
39
0
1

Year Published

2010
2010
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 56 publications
(40 citation statements)
references
References 49 publications
0
39
0
1
Order By: Relevance
“…Overall, three quarters of men on hemodialysis experience erectile dysfunction (8). Although phosphodiesterase-5 inhibitors improve erectile function in men with CKD, only a few small trials have evaluated such interventions (9).…”
Section: Introductionmentioning
confidence: 99%
“…Overall, three quarters of men on hemodialysis experience erectile dysfunction (8). Although phosphodiesterase-5 inhibitors improve erectile function in men with CKD, only a few small trials have evaluated such interventions (9).…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, the nicotine in cigarettes causes a decrease in ovarian follicles, reduces the movements of cilia of uterus, reduces testosterone and causes premature menopause (18).…”
Section: Discussionmentioning
confidence: 99%
“…The highest score for each dimention was 6 and the scores for all the scales are 36. International Index of Erectile Function Inventory scoring for men was mild impotence (21-25), average impotence (16)(17)(18)(19)(20), advanced impotence (10-15) and severe impotence (5)(6)(7)(8)(9)(10).…”
Section: Methodsmentioning
confidence: 99%
“…In several RCTs for treatment of sexual dysfunction in patients with CKD, treatment with sildenafil and vardenafil is associated with improvement in the overall score of IIEF-5, an increase of the score of all individual IIEF-5 tool domains (erection frequency, erection quality, penetration ability, maintenance frequency of penetration, maintenance of erection after penetration and erection confidence) compared to placebo and an increase of the overall satisfaction score of the IIEF-15 sexual assessment tool. For the use of other agents such as tadalafil or mirodenafil in CKD patients data is limited [61] . Sildenafil citrate is also considered an important first-line therapeutic option among kidney transplant recipients with sexual dysfunction as it has no effect on renal function or immunosuppressive drug levels [62] .…”
Section: First Line Therapy-oral Pharmacotherapymentioning
confidence: 99%